STOCK TITAN

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement

Elanco (NYSE: ELAN) will announce its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026.

(Neutral)
(Neutral)
Tags
conferences earnings

Elanco (NYSE: ELAN) will announce its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026. A conference call with the investment community and media will be held the same day starting at 8:00 a.m. Eastern Standard Time. Investors, media, and the public can access a live webcast via Elanco's investor website and a replay will be available on the site shortly after the call.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.
Argus Jan 22 session
+2.51% close to close Open Argus
Details

News Market Reaction – ELAN

On Jan 22, the day this news came out, ELAN closed 2.51% above the previous close.

Data tracked by StockTitan Argus for the Jan 22 session.

Market Context

This announcement sets the timetable for Elanco’s fourth quarter and full year 2025 financial result...
Analysis

This announcement sets the timetable for Elanco’s fourth quarter and full year 2025 financial results on February 24, 2026, with a conference call at 8:00 a.m. EST. It continues a pattern of regular earnings-date confirmations, for which past similar releases saw an average move of 3.49%. Investors following the story may focus on how forthcoming results align with prior Investor Day targets and recent product approvals, using the call to assess execution and outlook for 2026 and beyond.

Key Figures

Earnings release date: February 24, 2026 Conference call time: 8:00 a.m. EST Current price: $24.30 +5 more
Earnings release date
February 24, 2026
Q4 and full year 2025 results announcement date
Conference call time
8:00 a.m. EST
Start time for Q4 and full year 2025 call
Current price
$24.30
Price before Q4/FY25 earnings-date announcement
52-week range
$8.02–$24.98
52-week low and high before this news
Average move on similar news
3.49%
Average 24h move for 4 prior earnings-date announcements
Dimensional stake
25,082,545 shares (5.0%)
Schedule 13G passive ownership as of 12/31/2025
Short interest
4.18%
Reported short percent of float
Days to cover
3.55
Short interest days-to-cover metric

Historical Context

5 past events · Latest: Jan 06
5 events
  1. Jan 06

    Conference participation

    24h Move
    +3.3%

    Participation in J.P. Morgan Healthcare Conference with leadership Q&A.

  2. Dec 31

    Product approval

    24h Move
    -0.6%

    USDA approval for Befrena in canine dermatology market.

  3. Dec 18

    Product approval

    24h Move
    +0.1%

    FDA conditional approval for Credelio Quattro-CA1 for screwworm.

  4. Dec 09

    Investor Day targets

    24h Move
    -5.8%

    Three-year plan with growth, leverage and cost-savings goals.

  5. Nov 26

    Governance/partnership

    24h Move
    -0.2%

    Elanco executive appointed as Neurizon board observer.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

INDIANAPOLIS, Jan. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.

The conference call will begin at 8:00 a.m. Eastern Standard Time. Investors, media, and the general public can access a live webcast of the conference call through the link that will be posted on Elanco's website at https://investor.elanco.com/events-and-presentations/default.aspx. A replay will also be available on the website shortly following the call.

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ sustainability pillars – all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com

Investor Contact: Tiffany Kanaga (765) 740-0314 tiffany.kanaga@elancoah.com
Media Contact: Colleen Parr Dekker (317) 989-7011 colleen.dekker@elancoah.com  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/elanco-confirms-date-and-conference-call-for-fourth-quarter-and-full-year-2025-financial-results-announcement-302667237.html

SOURCE Elanco Animal Health

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Elanco (ELAN) release Q4 and full-year 2025 results?

Elanco will release fourth quarter and full year 2025 results on February 24, 2026.

What time is the Elanco (ELAN) earnings conference call on February 24, 2026?

The conference call begins at 8:00 a.m. Eastern Standard Time on February 24, 2026.

How can I listen to Elanco (ELAN) Q4 2025 results conference call?

Listen via the live webcast linked on Elanco's investor site at the events and presentations page.

Will a replay of Elanco's (ELAN) February 24, 2026 call be available?

Yes. A replay will be posted on Elanco's investor website shortly after the call.

Who is the intended audience for Elanco's (ELAN) February 24, 2026 call?

The call is for the investment community, media, and the general public.

Keep reading